Published in Cancer Weekly, February 2nd, 1998
Electroporation therapy uses electric fields generated by the Genetronics proprietary MedPulser to open momentary pores in human cells that allow more efficient entrance of an anti-tumor drug previously injected into the tumor. Genetronics believes preliminary data shows that very low dosages of the drug, Bleomycin, can be effective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.